Canadian Microbiome Workshop 2014: From Research to Applications – Appendix 1

Table of Contents ]

February 12-14, 2014
Westin Bayshore Hotel, Vancouver, BC

Appendix 1: Participants List

Name and Organization Background
Johane Allard
Professor
University of Toronto and
Director of the Nutritional Support Program
University Health Network
Toronto, Ontario
johane.allard@uhn.on.ca
Research Interests:
  • Nutrition and gastrointestinal disorders, including non-alcoholic fatty liver disease and inflammatory bowel disease
  • Obesity, malnutrition and nutrition support
  • Dr. Allard is a co-chair of the Canadian Malnutrition Task Force
Dr. Allard's team is managing the Canadian Home Total Parenteral Nutrition (HTPN) Registry
Emma Allen-Vercoe
Associate Professor
Molecular Biology and Genetics
University of Guelph
Guelph, Ontario
eav@uoguelph.ca
Research Interests:
  • Developing new techniques to culture and study novel bacterial species from the gut
  • Developing cutting-edge methods to image and characterize microbial interactions within the gut
  • Determining which species of the gut microflora can behave pathogenically towards the host with a focus on: Inflammatory Bowel Disease (IBD), regressive (late-onset) autism, recurrent (refractive) C. difficile infection (CDI) and colorectal cancer
Glen Armstrong
Professor and Head, Department of Microbiology, Immunology& Infectious Diseases
University of Calgary
Calgary, Alberta
glen.armstrong@ucalgary.ca
Research Interests:
  • Microbial pathogenesis
  • E. coli infection
  • C. difficile
Robert Beiko
Professor
Faculty of Computer Science
Dalhousie University
Halifax, Nova Scotia
beiko@cs.dal.ca
Research Interests:
  • Member of one of the 7 CIHR funded Canadian Microbiome Initiative team
  • Comparative, functional, and evolutionary genomics / bioinformatics focused mainly on bacterial evolution
  • Analysis of real data and modeling, Metagenomics
  • Construction of sophisticated and efficient algorithms that address the problems inherent in biological sequence data
Cindy Bell
Executive Vice-President
Corporate Development
Genome Canada
Ottawa, ON
cbell@genomecanada.ca
Genome Canada is a catalyst for developing and applying genomic sciences. Genome Canada works in partnership to invest in and manage large-scale research and translate discoveries into commercial opportunities, new technologies, applications and solutions, building bridges between government, academia and industry to forge a genomics-based public-private innovation focused on key life science sectors.
Premysl Bercik
Assistant Professor
Department of Medicine
McMaster University
Hamilton, Ontario
bercikp@mcmaster.ca
Research Interests:
  • The role of low-grade inflammation in the pathophysiology of gut dysfunction
  • The effect of gut inflammation on CNS function and gut-brain axis
  • The role of microbiota in functional GI diseases
  • Development of new techniques to study gastrointestinal motility, including videofluoroscopy image analysis and magnet-tracking
Michel Bergeron
Professor and Chairman of the Division of Microbiology and of the Infectious Diseases Research Centre
Université Laval
Québec City, Québec
michel.g.bergeron@crchul.ulaval.ca
Research Interests:
  • The development of DNA-based diagnostic tests for the detection of microbes and their associated antibiotic resistance genes
John Bienenstock
Professor
Departments of Medicine & Pathology and Molecular Medicine
McMaster University
Hamilton, Ontario
Bienens@mcmaster.ca
Research Interests:
  • Comparative immunology, immunopathology and immunophysiology of mucosal tissue
  • Mucosal immunology and its alteration in a variety of disease models
  • The role of neuroimmune interactions in allergy and inflammation and the reciprocal communication which occurs between these two systems
  • Mechanisms of action of probiotic organisms on the nervous system, behavior and in various models of inflammation
Graeme Boniface
Chief Operating Officer
Vancouver Prostate Centre
Vancouver, BC, Canada
gboniface@prostatecentre.com
PC–TRiADD
Vancouver Prostate Centre
The Vancouver Prostate Centre (VPC) is a UBC and VGH Centre of Excellence and Centre of Excellence for Commercialization and Research (CECR). The Centre’s research focuses on the discovery of molecular mechanisms of cancer progression, therapeutic resistance, and the development of new treatments, services, and products to improve cancer patient care. The VPC comprises a multi-disciplinary team of 21 senior bench and clinical scientists and more than 130 staff in three state-of-the-art facilities. The VPC integrates the expertise of scientists and clinicians in urology, cellular and molecular biology, pharmacology, socio-behavioural sciences, functional genomics, and medical oncology.
Judy Bray
Consultant
CIHR Institute of Infection and Immunity judybrayconsulting@gmail.com
The CIHR Institute of Infection and Immunity (III) supports research and helps to build research capacity in the areas of infectious disease and the body's immune system. Through the Institute's programs, researchers address a wide range of health concerns related to infection and immunity including disease mechanisms, disease prevention and treatment, and health promotion through public policy.
Fiona Brinkman
Professor
Department of Molecular Biology and Biochemistry
Simon Fraser University
Burnaby, British Columbia
brinkman@sfu.ca
Research Interests:
  • Leading bioinformatics and identifying biomarkers and PCR texts, for multiple Genome Canada and NSERC microbiome studies, including for water quality testing and some biofilm studies.
  • Assessing accuracy of bioinformatics methods for metagenomics analysis.
James Brown
Director, Computational Biology for Infectious Disease
GlaxoSmithKline
Collegeville, USA
James.R.Brown@gsk.com
Dr. James Brown leads the Microbiome Matrix Team which coordinates microbiome research in Research and Development at GlaxoSmithKline, one of the world’s leading research-based pharmaceutical and health-care companies.
Harry Brumer
Michael Smith Laboratories
University of British Columbia
Vancouver
brumer@msl.ubc.ca
Research Interests:
  • Fundamental and applied carbohydrate enzymology.
  • Breakdown of dietary fibre (non-starch polysaccharides) by the human gut microbiota
Ken Chan
Vice-President, Advocacy, Research & Healthcare
Cystic Fibrosis Canada
Toronto, Ontario
kchan@cysticfibrosis.ca
Cystic Fibrosis Canada’s mission is to help people with cystic fibrosis (CF). The Foundation funds research towards the goal of a cure or control for CF, and supports high quality CF care, promotes public awareness of CF and raises and allocates funds for these purposes.
David Charest
Director, Sector Development
Genome BC
Vancouver, BC
dcharest@genomebc.ca
Genome British Columbia is a catalyst for the life sciences cluster on Canada's West Coast, and manages a cumulative portfolio of over $625M in research projects and science and technology platforms. Working with governments, academia and industry across sectors such as forestry, fisheries, agriculture, environment, bioenergy, mining and human health, the goal of the organization is to generate social and economic benefits for British Columbia and Canada.
Stephen Collins
Associate Dean, Research
Faculty of Health Sciences and Professor
Department of Medicine, Gastroenterology
McMaster University
Hamilton, Ontario
scollins@mcmaster.ca
Research Interests:
  • The pathophysiology of intestinal diseases (post-infective irritable bowel syndrome)
  • Participation of muscle and nerves in the inflammatory process via activation of lymphocytes through antigen presentation, adhesion molecule expression and cytokine production
  • Mechanisms underlying the ability of intestinal microbiota to influence gut physiology and to influence the gut-brain axis
Jacques Corbeil
Canada Research Chair in Medical Genomics
Professor, Department of Molecular Medicine
Faculty of Medicine
Université Laval
Québec City, Québec
jacques.corbeil@crchul.ulaval.ca
Research Interests:
  • Understanding host-pathogen interactions
  • Metagenomics software RAY and RAY meta.
  • System biology approaches and kernel-based algorithms to assist with the massive amount of data coming out of the new sequencing and protein interactome technologies
Kenneth Croitoru
Professor of Medicine
University of Toronto and Division of
Gastroenterology
Mount Sinai Hospital
Toronto, Ontario
Kcroitoru@mtsinai.on.ca
Research Interests:
  • PI of one of the 7 CIHR funded Canadian Microbiome Initiative team
  • Basic science of Inflammatory Bowel Disease (IBD) - focus on T cell biology and regulatory T cells in animal models of colitis
  • Clinical Research in IBD - Project Leader for CCFC sponsored Multi-Centered Canadian Prospective Cohort study of Individuals at risk for Crohn’s disease to identify the Genetic, Environmental and Microbial Factors triggering or causing Crohn’s disease (GEM Project).
Dennis Cvitkovitch
Associate Professor
Oral Microbiology
Faculty of Dentistry
University of Toronto
Toronto, Ontario
d.cvitkovitch@dentistry.utoronto.ca
Research Interests:
  • The role of the acid tolerance response of Streptococcus mutans, the principal agent of dental caries
  • The mechanisms of cell-cell signalling and its role in biofilm formation and genetic exchange by gram positive pathogens; potential vaccine targets for Streptococcus pyogenes infections
  • The effects of dental restorative materials on bacterial growth and metabolism
Alan Davidson
Professor
Department of Biochemistry
University of Toronto
Toronto, Ontario
alan.davidson@utoronto.ca
Research Interests:
  • Mechanisms regulating tailed phage assembly pathways, which includes protein structure determination, bioinformatics, mutagenesis, and in vivo functional assays
  • Survival and behaviour of bacterial populations
  • Pseudomonas aeruginosa
Julian Davies
Professor Emeritus
UBC, Vancouver
jed@interchange.ubc.ca
Research Interests:
  • Microbiome
  • Antibiotic resistance
  • Suppression of resistance mechanisms
  • Natural sources of antibiotics
  • Role of antibiotics in nature
Emmanuel Denou
Research Assistant
Farcombe Family Digestive Health Research Institute
McMaster University
Hamilton, Ontario
denou@univmail.cis.mcmaster.ca
Research Interests:
  • Microbiome and the gut/brain interaction
  • Depression/anxiety
Serge Desnoyers
Assistant Director
CIHR Institute of Infection and Immunity
Centre de recherche du CHU de Québec
CHUL Québec, QC
serge.desnoyers@crchul.ulaval.ca
The CIHR Institute of Infection and Immunity (III) supports research and helps to build research capacity in the areas of infectious disease and the body's immune system. Through the Institute's programs, researchers address a wide range of health concerns related to infection and immunity including disease mechanisms, disease prevention and treatment, and health promotion through public policy.
Edie Dullaghan
Head, Target Validation
Centre for Drug Research and Development (CDRD)
Vancouver, British Columbia
edullaghan@cdrd.ca
The Centre for Drug Research and Development (CDRD) is Canada’s fully-integrated national drug development and commercialization centre, providing expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).
Nancy Edwards
Scientific Director of the CIHR Institute of Population and Public Health
University of Ottawa
Ottawa
Nancy.Edwards@uottawa.ca
Research Interests:
  • Public and population health.
  • Health services, policy and clinical research
  • The design and evaluation of complex multi-level and multi-strategy community health programs.
  • Global health spanning four continents including development-oriented and research-focused projects
Hani El-Gabalawy
Scientific Director of the CIHR Institute of Musculoskeletal Health and Arthritis
University of Manitoba
Winnipeg
Hani.Elgabalawy@med.umanitoba.ca
Research Interests:
  • The mechanisms initiating and sustaining joint inflammation in rheumatoid arthritis; early inflammatory arthritis and the pathological features seen in the inflamed joints,
  • Therapeutic strategies on the early stages of joint inflammation, before permanent progressive damage occurs.
  • Synovial biology, the pathogenesis of early arthritis,
  • Established a unique First Nations cohort to study gene-environment interactions in the pre-clinical phase of arthritis.
Dusko Ehrlich
Research Director
Microbial Genetics Unit
INRA Research Centre of Jouy-en-Josas
France
dusko.ehrlich@jouy.inra.fr
Research Interests:
Dr. Ehrlich is the head of the EU MetaHIT Project financed by the European Commission. Its objective is to establish associations between the genes of the human intestinal microbiota and our health and disease.
Peter Ernst
Professor
Department of Pathology
University of California, San Diego
pernst@ucsd.edu
Research Interests:
  • Understanding the role of Th cells in the pathogenesis of gastroduodenal disease in humans infected with H. pylori
  • Using mouse models of chronic colitis to study lymphoepithelial cell interactions
Karimah Es Sabar
President and CEO
Centre for Drug Research and Development (CDRD)
Vancouver, British Columbia
kessabar@cdrd.ca
The Centre for Drug Research and Development (CDRD) is Canada’s fully-integrated national drug development and commercialization centre, providing expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).
Jeff Farber
Director, Bureau of Microbial Hazards
Health Canada
Ottawa, Ontario
jeff.farber@hc-sc.gc.ca
The Bureau of Microbial Hazards is responsible for policy, standard setting, risk assessment, research and evaluation activities with respect to microbial hazards and extraneous material in the food supply. The primary objective of the work is to minimize health risks which may result from consumption of foods contaminated with microbial, parasitic and extraneous material hazards
Aida Fernandes
Chief Science and Education Officer
Crohn’s and Colitis Foundation of Canada (CCFC)
Toronto, Ontario
afernandes@CCFC.ca
CCFC is committed, first and foremost, to raising funds for research into inflammatory bowel disease (IBD). CCFC believes it is important to raise awareness about Crohn’s disease and ulcerative colitis by educating people with IBD, their families, health professionals and the general public about these diseases.
Brett Finlay
Professor
Michael Smith Laboratories
University of British Columbia
Vancouver, British Columbia
bfinlay@interchange.ubc.ca
Research Interests:
  • PI of one of the 7 CIHR funded Canadian Microbiome Initiative team
  • Host-pathogen interactions, at the molecular level
  • Cellular microbiology
  • Pathogenic bacteria, with Salmonella and pathogenic E. coli interactions with host cells being the primary focus
Abigail Forson
Assistant Director,
CIHR Institute of Gender and Health
Canadian Institutes of Health Research
Ottawa, Ontario
Abigail.forson@cihr-irsc.gc.ca
The CIHR Institute of Gender and Health (IGH)'s mission is to foster research excellence regarding the influence of gender and sex on the health of women and men throughout life, and to apply these research findings to identify and address pressing health challenges.
Elisabeth Fowler
Assistant Director
CIHR Institute of Human Development, Child and Youth Health
Canadian Institutes of Health Research
Ottawa, Ontario
elisabeth.fowler@cihr-irsc.gc.ca
The CIHR Institute of Human Development, Child and Youth Health (IHDCYH) supports research that ensures the best start in life for all Canadians and the achievement of their potential for optimal growth and development. IHDCYH promotes and support research that improves the health and development of mothers, infants, children, youth, and families in Canada and throughout the world.
Humphrey Gardner
VP Translational Medicine
AstraZeneca
Boston, USA
Humphrey.Gardner@astrazeneca.com
Among the core focus areas of Astrazeneca in the development of new medicines are metabolic, respiratory and inflammatory diseases. The microbiome has emerged as a relevant target for understanding, and even therapy, in these areas among others. As Head of Translational Medicine for Infection at AZ, Humphrey developed the bacterial genome sequencing programme and serves to coordinate efforts in the microbiome.
Deanna Gibson
Assistant Professor
Biology
University of British Columbia
Vancouver, British Columbia
deanna.gibson@ubc.ca
Research Interests:
  • Dietary modulation of the intestinal microbiome
  • Immune responses and susceptibility to inflammatory bowel diseases.
Sally Greenwood
Vice President, Communications and Education
Genome BC
Vancouver, British Columbia sgreenwood@genomebc.ca
Genome British Columbia is a catalyst for the life sciences cluster on Canada's West Coast, and manages a cumulative portfolio of over $625M in research projects and science and technology platforms. Working with governments, academia and industry across sectors such as forestry, fisheries, agriculture, environment, bioenergy, mining and human health, the goal of the organization is to generate social and economic benefits for British Columbia and Canada.
Robert Gruninger
Genome Alberta and Agriculture and Agri-Food Canada,
Lethbridge Research Centre,
Lethbridge, Alberta
Robert.Gruninger@AGR.GC.CA
Research Interests:
  • Enzyme discovery using a functional genomic approach
  • Protein structure-function relationship
  • Rumen/anaerobic microbiology
David Guttman
Director, Centre for the Analysis of Genome Evolution and Function and
Professor, Cell and Systems Biology
University of Toronto
Toronto, Ontario
david.guttman@utoronto.ca
Research Interests:
  • PI of one of the 7 CIHR funded Canadian Microbiome Initiative team
  • Evolution of host specificity and virulence
  • Comparative genomics
  • Metagenomics
  • Evolution and ecology of the Pseudomonas
Stephen Hallam
Assistant Professor
University of British Columbia
Vancouver, British Columbia
shallam@mail.ubc.ca
Research Interests:
  • Environmental genomics exploring the microcosmos, describing microbial community structure and function across a wide range of natural and human engineered ecosystems
  • Interdisciplinary tools sourced from ecology, molecular biology, genetics and computer science used to study distributed networks of metabolite exchange and feedback regulation
Jennifer Hamilton
Biotechnology Industry Advisor
Johnson and Johnson Family of Companies, Canada
West Vancouver, British Columbia
jjh@axionet.com
Johnson & Johnson Inc. is a leader in the consumer health care market, marketing leading brands in the baby, skin, hair, oral, wound and many other health, beauty and personal care categories.
Bettina Hamelin
Director, R&D
Pfizer, Canada
Vancouver, British Columbia
bettina.hamelin@pfizer.com
Pfizer is a multinational pharmaceutical corporation dedicated to developing innovative medications to prevent and treat diseases.
James Hogg
Professor Emeritus of Pathology
University of British Columbia
Vancouver, British Columbia
Jim.Hogg@hli.ubc.ca
Research Interests:
  • Inflammatory processes in the lung
  • Structure and function of the lungs in COPD.
Robert Holt
Head of Sequencing
Michael Smith Genome Sciences Centre, BC Cancer Research Agency
Vancouver, British Columbia
rholt@bcgsc.ca
Research Interests:
  • Metagenomic sequencing of tumours to find microbial signatures associated with various types of cancer
  • Developing laboratory methods for constructing large DNA molecules, engineering whole microbial genomes and exploring microbial genome interaction
  • Technology development in DNA sequencing
David Huntsman
Professor
Departments of Pathology and Laboratory Medicine and Obstetrics and Gynaecology
University of British Columbia
Vancouver, British Columbia
dgh@mail.ubc.ca
Research Interests:
  • Studies genetic predisposition to ovarian cancer
  • Development of predictive and prognostic tissue based cancer biomarkers of hereditary gastric cancer and a wide variety of other tumor types
  • Working with Professor Pieter Cullis on the creation of broad based personalized medicine initiative for British Columbia
David Hwang
Associate Professor, Pathology
University of Toronto and
Affiliate Scientist, Division of Experimental Therapeutics - Respiratory & Critical Care
Ontario Cancer Institute
Toronto, Ontario
David.Hwang@uhn.ca
Research Interests:
  • Bacterial community-wide gene expression and its role in antibiotic response and resistance in the cystic fibrosis lung
  • Metagenomic characterization of the pulmonary microbiota in the cystic fibrosis lung
  • Lung transplantation and repair
Mohan Iyer
SVP, Corporate Development
Second Genome, Inc.
349 Allerton Avenue
South San Francisco, CA 94080
mohan@secondgenome.com
Second Genome brings microbiome science to the discovery and development of therapeutic products. The company has established a pipeline of microbiome modulators that impact infection, immunity and metabolic diseases. Second Genome’s development pipeline is fueled by novel technologies for identifying, screening and scientifically validating product candidates and microbial biomarkers. Second Genome’s technologies have been rigorously validated through partnerships with leading pharmaceutical and nutrition companies, as well as academic and governmental research institutions.
Christian Jobin
Professor of Medicine
University of Florida
Gainesville, Florida, USA
Christian.Jobin@medicine.ufl.edu
christian_jobin@med.unc.edu
Research Interests:
  • Bacteria–host interaction in the intestines and the ensuing innate and immunological responses during health and disease, particularly in the context of carcinogenesis
Joy Johnson
Scientific Director
CIHR Institute of Gender and Health
University of British Columbia
Vancouver
joy.johnson@ubc.ca
Research Interests:
  • Health promotion and health behaviour change.
  • The social, structural and individual factors that influence the health behaviour of individuals.
  • Sex and gender issues in substance use and mental health.
Gabe Kalmar
Vice President, Sector Development
Genome BC
Vancouver, BC
gkalmar@genomebc.ca
Genome British Columbia is a catalyst for the life sciences cluster on Canada's West Coast, and manages a cumulative portfolio of over $625M in research projects and science and technology platforms. Working with governments, academia and industry across sectors such as forestry, fisheries, agriculture, environment, bioenergy, mining and human health, the goal of the organization is to generate social and economic benefits for British Columbia and Canada.
Danielle Kemmer
Program Manager
Genome Québec
Montreal, Quebec H3B 1S6 dkemmer@genomequebec.com
Research Interests:
  • Genomics and its application to health
  • Research partnerships and collaborations
  • Research administration and impact analysis
Malcolm King
Scientific Director of the CIHR Institute of Aboriginal Peoples’ Health
Simon Fraser University
Burnaby, British Columbia
malcolm_king@sfu.ca
Research Interests:
  • Pulmonary research,
  • New approaches to treat mucus clearance dysfunction in chronic lung disease,
  • Issues in airborne disease transmission,
  • Respiratory health inequities facing Aboriginal people.
Tobias Kollman
AssociateProfessor, Division of Infectious and Immunological Diseases, Department of Pediatrics
University of British Columbia
Vancouver, British Columbia
tkollmann@cw.bc.ca
Research Interests:
  • Immunology and immunological diseases
  • Developmental immunology/ neonatal immunology
  • Infectious disease
  • Vaccines
Anita Kozyrskyj
Associate Professor
Department of Pediatrics
University of Alberta
Edmonton, Alberta
kozyrsky@ualberta.ca
Research Interests:
  • PI of SyMBIOTA (Synergy in Microbiota) research program, one of the 7 CIHR-funded Canadian Microbiome Initiative teams
  • Early life determinants of childhood asthma such as birth mode, diet and antibiotic use
  • Pre- and postnatal influences on intestinal microbiota and their connection to the development of atopic disease
  • Population-based birth cohort studies and link them to existing healthcare databases
Tony Lam
Senior Scientist
Division of Advanced Diagnostics – metabolism
Toronto General Research Institute
MaRS Centre, Toronto
tlam@uhnresearch.ca
Research Interests:
  • Obesity
  • Diabetes
  • Glucose and energy homeostasis
  • Intestinal signaling defects
Paul Lasko
Scientific Director of the CIHR Institute of Genetics
McGill University
Montreal, Quebec
Paul.lasko@mcgill.ca
Research Interests:
  • Oogenesis and pole plasm assembly using the model organism Drosophila melanogaster, a.k.a. the fruit fly. Oogenesis is the process by which an egg is formed and matures.
Megan Levings
Canada Research Chair in Transplantation
Scientist, Child & Family Research Institute
Associate Professor, Dept. of Surgery
University of British Columbia
Vancouver, British Columbia
megan.levings@ubc.ca
Research Interests:
  • Understanding the role of T regulatory (Treg) cells in transplantation tolerance, cancer and inflammatory bowel disease.
  • Generation of Treg cells in vitro for use as a cellular therapy to replace standard immunosuppression in the context of organ transplantation or to restore tolerance in the context of autoimmunity
Marcia MacDonald
Manager, Scientific Affairs
Genome BC
Vancouver, British Columbia
mmacdonald@genomebc.ca
Genome British Columbia is a catalyst for the life sciences cluster on Canada's West Coast, and manages a cumulative portfolio of over $625M in research projects and science and technology platforms. Working with governments, academia and industry across sectors such as forestry, fisheries, agriculture, environment, bioenergy, mining and human health, the goal of the organization is to generate social and economic benefits for British Columbia and Canada.
David Mack
Senior Scientist, CHEO Research Institute
Director, CHEO Inflammatory Bowel Disease Centre
Chief, Division of Gastroenterology, Hepatology & Nutrition, CHEO
Professor, Department of Pediatrics, Faculty of Medicine, University of Ottawa
DMack@cheo.on.ca
Research Interests:
  • Pediatric IBD
  • Gut inflammation
  • Predicting outcomes
  • Developing new therapeutics
  • Understanding natural h story of pediatric IBD
Joaquin Madrenas
Canada Research Chair in Human Immunology Professor and Chairman
Department of Microbiology and Immunology
Director, McGill’s Microbiome and Disease Tolerance Centre
Executive Director, CIHR Human Immunology Network – Montreal, Québec
joaquin.madrenas@mcgill.ca
Research Interests:
Director of the Microbiome and Disease Tolerance Centre (MDTC) at McGill; Canada Research Chair in Human Immunology
  • Human Immunology: Regulation of adaptive immunity by innate immune mechanisms.
  • Functional Microbiomics: Mechanisms promoting commensalism by pathobionts.
Karen Madsen
Professor
Division of Gastroenterology
University of Alberta
Edmonton, Alberta karen.madsen@ualberta.ca
Research Interests:
Co-director of the “Center of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR)” and the Alberta IBD Consortium
  • The role of intestinal permeability and gut microbes in human health
  • The mechanisms of breakdown and repair of mucosal barrier integrity
  • How probiotic bacteria interact with and modulate host epithelial and immune cell activity
Amee Manges
Associate Professor
School of Population and Public Health
University of British Columbia
Vancouver, British Columbia
amee.manges@ubc.ca
Research Interests:
  • Microbial metagenomics
  • Intestinal microflora
  • C. difficile infections
Eric Marcotte
Associate Director, Institute of Genetics & Institute of Neurosciences, Mental Health and Addiction
Canadian Institutes of Health Research (CIHR)
eric.marcotte@mcgill.ca
Research Interests:
  • Molecular mechanisms underlying neurodegenerative and neurodevelopmental disorders, especially Parkinson's disease and schizophrenia.
  • Regenerative medicine
  • Epigenetics
  • Commercialization of modern biotechnology
Sylvie Masse
CIHR Institute of Infection and Immunity
Centre de recherche du CHU de Québec
CHUL – local TR-62
2705, boul. Laurier
Québec, QC G1V 4G2
sylvie.masse@crchuq.ulaval.ca
The CIHR Institute of Infection and Immunity (III) supports research and helps to build research capacity in the areas of infectious disease and the body's immune system. Through the Institute's programs, researchers address a wide range of health concerns related to infection and immunity including disease mechanisms, disease prevention and treatment, and health promotion through public policy.
Debora C. Matthews
Professor and Assistant Dean (Research)
Faculty of Dentistry
Dalhousie University
Halifax, Nova Scotia Debora.Matthews@Dal.Ca
Research Interests:
Dr. Matthews is Director of the Network for Canadian Oral Health Research. The major objectives of this network are twofold:
  • Foster & support research infrastructure in the oral health research community to facilitate the development of collaborative interdisciplinary research teams; and,
  • Promote knowledge transfer and translation among researchers, health care practitioners, policy makers, business/industry and the general public.
Dennis McCormac
Director, Genomics Services and Technology Advisor
Ontario Genomics Institute and
The Centre for Applied Genomics
MaRS Centre,
Toronto, Ontario
dmccormac@OntarioGenomics.ca
As a part of the business development group at the Ontario Genomics Institute, it is our mandate is to help industry tap into the potential of life science solutions to improve business processes and promote the innovative use of life science research. We focus on relationships by identifying needs in a variety of industries, using our life science and business development expertise to connect companies to world-class researchers in the field and identify funding sources.
Janet McElhaney
Professor of Medicine, Medical Sciences Division, Northern Ontario School of Medicine
Member of Institute Advisory Board, CIHR Institute of Aging
jmcelhaney@hsnsudbury.ca
Research Interests:
  • Research on the elderly
  • Impact of immunosenescence on the immune responses to vaccination
  • Immunologic biomarkers of protection mediated by vaccination
  • Role of vaccination in preventing disability in older adults
Pierre Meulien
President
Genome Canada
Ottawa, Ontario
pmeulien@genomecanada.ca
Genome Canada is a catalyst for developing and applying genomic sciences. Genome Canada works in partnership to invest in and manage large-scale research and translate discoveries into commercial opportunities, new technologies, applications and solutions, building bridges between government, academia and industry to forge a genomics-based public-private innovation focused on key life science sectors.
Yassene Mohammed
Chief Bioinformatician
University of Victoria Genome British Columbia Proteomics Centre
Saanich, British Columbia
Yassene@proteincentre.com
Research Interests:
  • Mass Spectrometry-based Targeted and Non-targeted Proteomics
  • Bioinformatics for Proteomics and Meta-Proteomics
  • Automated Big Data Analysis using Scientific Workflow
William Mohn
Professor
Department of Microbiology and Immunology
University of British Columbia
Vancouver, British Columbia
wmohn@mail.ubc.ca
Research Interests:
  • Microbial degradation activities, addressing the biochemical mechanisms involved as well as the physiology, phylogeny and ecology of the organisms involved
Deborah Money
Professor, Division of Specialized Gynecology
University of British Columbia and
Vice-President, Research
BC Women’s Hospital and Health Centre
Vancouver, British Columbia
dmoney@cw.bc.ca
Research Interests:
  • PI of VOGUE, one of the 7 CIHR funded Canadian Microbiome Initiative team
  • Infectious diseases in obstetrics and gynecology, focused on viral pathogens in women and in pregnancy, specifically HIV, HPV, Hepatitis C and genital herpes
Josh Neufeld
Associate Professor
Department of Biology
University of Waterloo
Waterloo, Ontario
jneufeld@uwaterloo.ca
Research Interests:
  • Understanding the causes of microbial diversity and the relationship between taxonomic and functional diversity as it relates to ecosystem health.
  • Next-generation sequencing, bioinformatics, and stable-isotope probing for exploring the diversity and metabolic function of terrestrial, aquatic, and host-associated microbial communities.
Kieran O’Doherty
Assistant Professor
Applied Social Psychology
University of Guelph
Guelph, Ontario
kieran.odoherty@uoguelph.ca
Research Interests:
  • Social and ethical implications of genetics/genomics
  • Regulatory guidelines
Marc Ouellette
Scientific Director
CIHR Institute of Infection and Immunity
Université Laval
Québec City, Québec
Marc.Ouellette@crchul.ulaval.ca
Research Interests:
  • Antimicrobial resistance, specifically mechanisms of resistance in the parasite, Leishmania and the bacteria Streptococcus pneumoniae
  • Development of new tools to diagnose resistance, novel drug targets and novel pathways
  • Phage therapy
  • Whole genome analysis
Jackie Papkoff, Ph.D.
Vice President Immunology Scientific Innovation
J&J California Innovation Center
jpapkoff@its.jnj.com
Research Interests:
  • Identify and foster innovation across the pharmaceutical, medical devices, diagnostics and consumer product ecosystem
  • Invest in transformational opportunities from inception through clinical proof of concept
John Parkinson
Associate Professor
Biochemistry and Molecular and Medical Genetics
University of Toronto and
Senior Scientist, Molecular Structure and Function
Hospital for Sick Children
Toronto, Ontario
jparkin@sickkids.ca
Research Interests:
  • Meta-transcriptomics study of microbiomes
  • Evolution of biological complexity
  • Parasites and bacterial pathogens,
  • Computational systems biology
Anthony Phillips
Scientific Director, CIHR Institute of Neurosciences, Mental Health and Addiction
Strangway Building
University of British Columbia
Vancouver, British Columbia
aphillips@psych.ubc.ca
Research Interests:
The Institute of Neurosciences, Mental Health and Addiction (INMHA) supports research on the functioning and disorders of the brain, the spinal cord, the sensory and motor systems, and the mind.
Dana Philpott
Associate Professor
Department of Immunology
University of Toronto
Toronto, Ontario
dana.philpott@utoronto.ca
Research Interests:
  • Role of NOD receptors in bacterial infection and auto-immune diseases
  • Mucosal immunity, inflammation
Christopher Power
Professor
Division of Neurobiology
University of Alberta
Edmonton, Alberta
chris.power@ualberta.ca
Research Interests:
  • Microbiome in the brain and its relationship to disease
  • Neurovirology
  • Neuroimmunology
  • Neurodegeneration
  • Retrovirology
Lita Proctor
Program Director of the Human Microbiome Project
National Institutes of Health
Bethesda, Maryland, USA
lita.proctor@nih.gov
The Human Microbiome Project (HMP) is a 5-year, trans-NIH Common Fund Initiative to create a community resource for microbiome-related research.
Jennifer Raven
Associate, Strategic Initiatives
CIHR Institute of Infection and Immunity
Centre de recherche du CHU de Québec
CHUL
Québec City, Québec
jennifer.raven@crchul.ulaval.ca
The CIHR Institute of Infection and Immunity (III) supports research and helps to build research capacity in the areas of infectious disease and the body's immune system. Through the Institute's programs, researchers address a wide range of health concerns related to infection and immunity including disease mechanisms, disease prevention and treatment, and health promotion through public policy.
Gregor Reid
Professor
Microbiology and Immunology
Western University
London, Ontario
gregor@uwo.ca
Research Interests:
  • Understanding how indigenous and exogenously applied (probiotics) bacteria, especially lactobacilli confer health benefits primarily in the female gut, breast and urogenital tract
Raylene Reimer
Professor
Faculty of Kinesiology and Department of Biochemistry and Molecular Biology
University of Calgary
Calgary, Alberta
reimer@ucalgary.ca
Research Interests:
  • Understanding how maternal diet during pregnancy ‘programs’ the risk of obesity and impaired glucose tolerance in offspring
  • Understanding the link between the human host and intestinal microbial communities
  • Clinical trials with prebiotics.
Rachael Ritchie
Genome BC
Vancouver, British Columbia
rritchie@genomebc.ca
Genome British Columbia is a catalyst for the life sciences cluster on Canada's West Coast, and manages a cumulative portfolio of over $625M in research projects and science and technology platforms. Working with governments, academia and industry across sectors such as forestry, fisheries, agriculture, environment, bioenergy, mining and human health, the goal of the organization is to generate social and economic benefits for British Columbia and Canada.
Stephen Robbins
Scientific Director
CIHR Institute of Cancer Research
University of Calgary
Calgary, Alberta
srobbins@ucalgray.ca
Research Interests:
  • Deciphering how extracellular signals are recognized by cells to control cellular proliferation and differentiation.
  • Defining new therapies for malaria,
  • Novel classes of anti-inflammatory agents and new therapeutic targets for brain tumours.
  • The use of the Microarray Technology to define molecular blueprints of various childhood cancers.
Keeley Rose
Project Manager,
CIHR Institute of Nutrition, Metabolism and Diabetes
Hospital for Sick Children
Toronto, Ontario
keeley.rose@sickkids.ca
The CIHR Institute of Nutrition, Metabolism and Diabetes's (INMD) mandate supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver function
Denis Roy
Canada Research Chair in Lactic Cultures Biotechnology for Dairy and Probiotic Industries
Professor, Department of Food Science and Nutrition
Université Laval
Québec City, Québec
Denis.Roy@fsaa.ulaval.ca
Research Interests:
  • Study of microbial cultures for food production to understand how they function and to investigate their properties and purported health benefits
  • Applying molecular methodologies to micro-organisms in order to define their diversity and measure their gene expression
Anthony Schryvers
Professor
Department of Microbiology, Immunology and Infectious Diseases
University of Calgary
Calgary, Alberta
schryver@ucalgary.ca
Research Interests:
  • Pathogenesis of bacterial infections
  • Determine the detailed mechanisms involved in the iron uptake pathway and to develop effective vaccines and therapeutic agents against pathway components
  • Microbiota
Fraser Scott
Professor
Department of Medicine and Department of Biochemistry, Microbiology and Immunology
University of Ottawa and Senior Scientist, Chronic Disease Ottawa Hospital Research Institute
Ottawa, Ontario
fscott@ohri.ca
Research Interests:
  • Determine how dietary antigens influence the development of type I diabetes
  • Define abnormal gut immune responses to wheat peptide antigens in diabetes-prone animals and humans
Dilani Senadheera
Assistant Professor
Faculty of Dentistry
University of Toronto
Toronto, Ontario
dilani.senadheera@gmail.com
Research Interests:
  • Characterizing oral microbial community structures associated with human health or disease
  • Investigate the virulence mechanisms of the cariogenic pathogen,Streptococcus mutans at the molecular and genetic levels
Nilufer Seth
Principal Scientist
Immunoregulation Group, Immunoscience Research Unit, Pfizer, Inc.
Cambridge, MA 02140
Nilufer.seth@pfizer.com
Pfizer’s Host-Microbiome Group is dedicated to discovering medicines that will reshape the treatment of inflammatory and autoimmune diseases by harnessing strategies and pathways used by the human intestinal microbiota to maintain immune homeostasis. The group’s interests focus on identification of mechanism and pathways that induce, maintain and / or promote the function of regulatory and tolerogenic immune cell types. Our current projects focus on known immunomodulatory molecules, agonist and bacteria that have been observed to modulate key regulatory pathways.
Philip Sherman
Scientific Director of the CIHR Institute of Nutrition, Metabolism and Diabetes
Hospital for Sick Children
Toronto, Ontario
Philip.sherman@sickkids.ca
Research Interests:
  • Epithelial cell signal transduction responses to pathogenic, commensal, and probiotic bacteria
  • Microbiome
  • IBD
  • Pediatric gastroenterology
Bhagi Singh
Professor
Department of Microbiology and Immunology
Western University
London, Ontario
bhagi.singh@schulich.uwo.ca
Research Interests:
  • Defining a role of the lung microbiome in chronic obstructive pulmonary disease
  • The role of regulatory T cells in the pathogenesis of type I diabetes
Alain Stintzi
Associate Professor
Ottawa Institute of Systems Biology
University of Ottawa
Ottawa, Ontario
astintzi@uottawa.ca
Research Interests:
  • Microbial genomic, gene expression and regulation, microarray and functional genomic
  • Foodborne pathogens, host-pathogen interactions, colonization and virulence factors, animal models of human infection, and gut-microbe interactions
  • Campylobacter jejuni, iron acquisition and metabolism, and stress responses
Michael Surette
Professor
Department of Medicine
McMaster University
Hamilton, Ontario
mgsurette@gmail.com
Research Interests:
  • PI of one of the 7 CIHR funded Canadian Microbiome Initiative team
  • Investigating the role of normal flora-pathogen interactions in health and disease in the area of respiratory infections with a focus in cystic fibrosis
  • Identification of overlooked pathogens in airway disease and synergistic interactions between a virulent organisms and pathogens
Patrick Tang
Medical Microbiologist
BC Centre for Disease Control and
Clinical Associate Professor University of British Columbia, Vancouver, British Columbia
patrick.tang@bccdc.ca
Research Interests:
  • Infectious agents in cancer and chronic diseases
  • Genomic epidemiology of Mycobacterium tuberculosis
  • Viral genomics and metagenomics
  • Diagnostics
Elena Verdu
Associate Professor
Division of Gastroenterology
McMaster University
Hamilton, Ontario
verdue@mcmaster.ca
Research Interests:
  • Pathogenesis of chronic inflammatory disorders such as celiac disease
  • Investigating host-bacterial interactions in particular in the context of probiotics and functional gastrointestinal diseases
Jens Walter
Associate Professor
Food Science and Technology Department
University of Nebraska-Lincoln
Lincoln, Nebraska, USA
jwalter2@unl.edu
Research Interests:
  • Microbial ecology of the gastrointestinal tract
  • Characterizing the interplay between diet, the gut microbiota, and the metabolism and immune system of the host with the long-term goal to develop dietary strategies that modulate composition and functionality of the gut microbiota to prevent chronic diseases
George Weinstock
Professor
Genetics and Molecular Biology
Washington University
St. Louis, Missourri, USA
gweinsto@genome.wustl.edu
Associate Director of The Genome Institute - Sequencing the human microbiome as part of the NIH-funded Human Microbiome Project (HMP)
Research Interests:
  • Applies high-throughput DNA sequencing, genome-wide analysis, bioinformatics, and other genetic methods to the study of human, model organisms and microbial genomes
Benjamin Willing
Assistant Professor
Department of Agriculture, life and Environmental Sciences
University of Alberta
Edmonton, Alberta
willing@ualberta.ca
Research Interests:
  • Understand how different members of the resident flora contribute to the metabolism of the diet
  • Understanding the mechanisms through which microbes regulate host physiology
  • Metabolomics
  • Transcriptomics
  • Gut bacteria
Alan Winter
President and Chief Executive Officer
Genome BC
Vancouver, British Columbia
awinter@genomebc.ca
Genome British Columbia is a catalyst for the life sciences cluster on Canada's West Coast, and manages a cumulative portfolio of over $625M in research projects and science and technology platforms. Working with governments, academia and industry across sectors such as forestry, fisheries, agriculture, environment, bioenergy, mining and human health, the goal of the organization is to generate social and economic benefits for British Columbia and Canada.
David Wishart
Professor
Department of Biological Sciences
University of Alberta
Edmonton, Alberta
david.wishart@ualberta.ca
Research Interests:
  • Nanobiology
  • Genomics,
  • Proteomics,
  • Metabolomics,
  • Bioinformatics
  • Systems biology
William Yan
Director
Bureau of Nutritional Sciences
Food Directorate
Health Canada
William.Yan@hc-sc.gc.ca
The Health Canada Bureau of Nutritional Sciences comprises two Divisions: The Nutrition Evaluation Division and the Nutrition Research Division, who work in concert in four main program areas: Nutrition Labeling and Claims; Nutrition Quality and Safety; Special Purpose Foods for Vulnerable Groups; and Food Surveillance and Monitoring.
Colby Zaph
Assistant Professor
Pathology and Laboratory Medicine
University of British Columbia
Vancouver, British Columbia
colby@brc.ubc.ca
Research Interests:
  • Defining the molecular and cellular mechanisms that regulate immunity and inflammation at mucosal sites
  • The nematode parasite Trichuris muris and the bacterial pathogen Citrobacter rodentium
  • Epigenetic effects of microbiome on IBD
Date modified: